Merck (MRK) is a publicly traded Healthcare sector company. As of August 28, 2026, MRK trades at $147.58 with a market cap of $377.72B and a P/E ratio of 118.63. MRK moved -1.21% today. Year to date, MRK is +40.48%; over the trailing twelve months it is +77.88%. Its 52-week range spans $73.31 to $156.92. Analyst consensus is strong buy with an average price target of $150.20. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest MRK news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $147.58 |
| Market Cap | $377.72B |
| P/E Ratio | 118.63 |
| EPS | $1.27 |
| Dividend Yield | 0.85% |
| 52-Week High | $156.92 |
| 52-Week Low | $73.31 |
| Volume | 3.33M |
| Avg Volume | 0 |
| Revenue (TTM) | $66.57B |
| Net Income | $3.17B |
| Gross Margin | 72.97% |
16 analysts cover MRK: 0 strong buy, 12 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $150.20.